Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 28, 2017

DrugPatentWatch Database Preview

Megestrol acetate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for megestrol acetate and what is the scope of megestrol acetate patent protection?

Megestrol acetate
is the generic ingredient in three branded drugs marketed by Apotex Inc, Wockhardt, Barr, Par Pharm, Twi Pharms Inc, Teva, Usl Pharma, West-ward Pharms Int, Bristol Myers Squibb, Endo Pharms Inc, and Teva Pharms, and is included in sixteen NDAs. There are seven patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Megestrol acetate has one hundred and eighty-five patent family members in twenty-seven countries.

There are eighteen drug master file entries for megestrol acetate. Twenty-six suppliers are listed for this compound.

Summary for Generic Name: megestrol acetate

Drug Master File Entries: see list18
Suppliers / Packagers: see list26
Bulk Api Vendors: see list55
Clinical Trials: see list442
Patent Applications: see list6,277
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:megestrol acetate at DailyMed

Pharmacology for Ingredient: megestrol acetate

Ingredient-typeProgesterone Congeners
Drug ClassProgestin
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int
megestrol acetate
TABLET;ORAL074458-002Sep 29, 1995ABRXNoNo► Subscribe► Subscribe
Endo Pharms Inc
megestrol acetate
SUSPENSION;ORAL021778-001Jul 5, 2005ABRXYesYes9,101,540► SubscribeY ► Subscribe
Par Pharm
megestrol acetate
TABLET;ORAL072423-001Aug 8, 1988ABRXNoYes► Subscribe► Subscribe
Bristol Myers Squibb
megestrol acetate
TABLET;ORAL016979-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe
Endo Pharms Inc
megestrol acetate
SUSPENSION;ORAL021778-001Jul 5, 2005ABRXYesYes7,101,576► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Find generic sources and suppliers
  • Formulary management
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus